Comparative Pharmacology
Head-to-head clinical analysis: SODIUM LACTATE 1 6 MOLAR IN PLASTIC CONTAINER versus SODIUM LACTATE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SODIUM LACTATE 1 6 MOLAR IN PLASTIC CONTAINER versus SODIUM LACTATE IN PLASTIC CONTAINER.
SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER vs SODIUM LACTATE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Sodium lactate is a source of bicarbonate precursor. It is metabolized to bicarbonate in the liver, which buffers metabolic acidosis, restoring acid-base balance.
Sodium lactate is converted to bicarbonate in the liver, providing an alkalizing effect to correct metabolic acidosis.
Intravenous infusion: The typical adult dose is 300-500 mL of 1/6 Molar sodium lactate solution (approximately 167 mEq/L each of sodium and lactate, 1 L contains 167 mEq of sodium and lactate) administered as a continuous intravenous infusion at a rate of 0.5-2.5 mL/kg/hour, adjusted based on the severity of acidosis and clinical response. Maximum infusion rate: 2.5 mL/kg/hour.
Intravenous (IV) infusion: Initial dose 300-500 mL of 1/6 M (M/6) sodium lactate solution (167 mEq/L of sodium and lactate) infused over 1-2 hours; subsequent doses based on serum bicarbonate levels and clinical response.
None Documented
None Documented
30–60 minutes for lactate conversion; bicarbonate component determined by CO2 excretion.
The terminal elimination half-life of lactate is approximately 5–10 minutes due to rapid hepatic metabolism; this short half-life allows quick correction of metabolic acidosis when administered intravenously.
Primarily renal as bicarbonate and lactate; <5% unchanged.
Sodium lactate is metabolized to bicarbonate in the liver via the Cori cycle; less than 5% is excreted unchanged in urine under normal conditions. Biliary/fecal elimination is negligible.
Category C
Category C
Electrolyte Solution
Electrolyte Solution